Establishment Labs (ESTA) vs Willis Lease Finance (WLFC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Establishment Labs (ESTA) has outperformed Willis Lease Finance (WLFC) over the past year, gaining 51.1% versus a loss of 11.4%. Over five years, WLFC leads with a +194.8% price change compared with -21.3% for ESTA. Establishment Labs is the larger company by market cap ($1.82 billion vs $854.9 million), about 2.1 times the size.
On valuation, Willis Lease Finance trades at a lower forward P/E (5.9x vs 1017.0x for Establishment Labs). Willis Lease Finance pays a dividend yielding 1.19%, while Establishment Labs does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ESTA | WLFC |
|---|---|---|
| Share price | $61.02 | $40.43 |
| Market cap | $1.82B | $854.86M |
| 1-day change | +0.68% | +1.05% |
| YTD return | -16.84% | -11.51% |
| 1-year return | +51.07% | -11.37% |
| 5-year return | -21.29% | +194.84% |
| P/E ratio (TTM) | — | 10.18 |
| Forward P/E | — | 5.89 |
| EPS (TTM) | $-1.30 | $3.97 |
| Dividend yield | 0.00% | 1.19% |
| Annual dividend | $0.00 | $0.483 |
| Revenue (latest FY) | $211.08M | — |
| Revenue growth (YoY) | +27.14% | — |
| Net income (latest FY) | $-51.06M | — |
| Gross margin | 69.32% | — |
| Operating margin | -18.48% | — |
| Net margin | -24.19% | — |
| 52-week high | $97.59 | $81.54 |
| 52-week low | $38.38 | $38.00 |
| Distance from 52-week high | -37.47% | -50.42% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +67.88% | +86.74% |
| Average volume | 427.13K | 233.38K |
| Shares outstanding | 29.80M | 21.14M |
| Employees | 1,004 | 467 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Establishment Labs is about 2.1 times larger than Willis Lease Finance by market value ($1.82B vs $854.86M).
- ESTA has outperformed WLFC by 62.4 percentage points over the past year.
- Willis Lease Finance offers a meaningfully higher dividend yield (1.19% vs 0.00%).
- The two companies sit in different sectors: Establishment Labs in Health Care and Willis Lease Finance in Consumer Discretionary.
About Establishment Labs
ESTA stock →Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand.
Health Care · Industrial Specialties · 1,004 employees
About Willis Lease Finance
WLFC stock →Willis Lease Finance Corporation, together with its subsidiaries, operates as a lessor and servicer of commercial aircraft and aircraft engines worldwide. It operates in two segments, Leasing and Related Operations, and Spare Parts Sales.
Consumer Discretionary · Industrial Specialties · 467 employees
ESTA vs WLFC FAQ
Which is bigger, Establishment Labs or Willis Lease Finance?
Establishment Labs (ESTA) is larger, with a market capitalization of $1.82B compared with $854.86M for Willis Lease Finance (WLFC).
Which stock has performed better over the past year, ESTA or WLFC?
ESTA returned +51.07% over the past 12 months, compared with -11.37% for WLFC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Establishment Labs or Willis Lease Finance?
Willis Lease Finance pays a dividend yielding 1.19%, while Establishment Labs does not currently pay a regular dividend.
Are Establishment Labs and Willis Lease Finance in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.